Musso Alan A
Insider CIK 1295830 · TRGT SVP, Fin+Admin, CFO & Treas · BLCM CFO and Treasurer · ALRN Director · FULC Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 170,000 | — | $0 | 170,000 | SEC↗ |
| RNTX Rein Therapeutics, Inc. | A Award deriv | 2025-07-23 | 2025-07-23 | 17,500 | — | $0 | 17,500 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2025-01-24 | 2025-01-28 | 285,000 | — | $0 | 285,000 | SEC↗ |
| ALRN Aileron Therapeutics, Inc. | A Award deriv | 2024-12-02 | 2024-12-06 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ALRN Aileron Therapeutics, Inc. | A Award deriv | 2024-08-20 | 2024-08-22 | 2,725 | — | $0 | 2,725 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2024-01-26 | 2024-01-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2024-01-17 | 2024-01-19 | 61,822 | — | $0 | 61,822 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | A Award deriv | 2023-10-31 | 2023-11-02 | 5,450 | — | $0 | 5,450 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2023-08-07 | 2023-08-09 | 432,800 | — | $0 | 432,800 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-07-02 | 2018-07-05 | 52,500 | — | $0 | 52,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2018-05-25 | 2018-05-29 | 6,206 | $7.97 | $49.5K | 26,548 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise deriv | 2018-01-03 | 2018-01-05 | 1,875 | — | $0 | 5,625 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | F Tax w/h | 2018-01-03 | 2018-01-05 | 706 | $9.79 | $6.9K | 32,754 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | M Exercise | 2018-01-03 | 2018-01-05 | 1,875 | — | $0 | 33,460 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2017-12-11 | 2017-12-13 | 17,117 | $9.33 | $159.7K | 31,585 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2017-11-27 | 2017-11-29 | 6,206 | $9.89 | $61.4K | 48,702 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-07-03 | 2017-07-06 | 31,500 | — | $0 | 31,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2017-05-25 | 2017-05-26 | 6,311 | $12.24 | $77.2K | 54,908 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 13,500 | — | $0 | 13,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-11-28 | 2016-11-29 | 22,427 | $19.23 | $431.3K | 61,148 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-11-28 | 2016-11-29 | 600 | $19.85 | $11.9K | 60,548 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-11-25 | 2016-11-29 | 6,273 | $20.48 | $128.5K | 83,575 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2016-01-04 | 2016-01-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-11-24 | 2015-11-27 | 29,300 | $22.34 | $654.6K | 88,742 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2015-02-24 | 2015-02-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2014-12-18 | 2014-12-22 | 117,647 | — | $0 | 117,647 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award | 2014-12-18 | 2014-12-22 | 117,647 | — | $0 | 117,647 | SEC↗ |
| TRGT TARGACEPT INC | A Award | 2014-10-17 | 2014-10-21 | 55,000 | — | $0 | 57,799 | SEC↗ |
| TRGT TARGACEPT INC | A Award deriv | 2014-01-23 | 2014-01-24 | 55,000 | — | $0 | 55,000 | SEC↗ |
| TRGT TARGACEPT INC | A Award deriv | 2013-01-17 | 2013-01-18 | 65,000 | — | $0 | 65,000 | SEC↗ |
| TRGT TARGACEPT INC | A Award deriv | 2012-05-04 | 2012-05-08 | 100,000 | — | $0 | 100,000 | SEC↗ |